Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Sonoma Pharmaceuticals, Inc. (SNOA) had Return on Investments of -17.59% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$3.75M |
|
$-0.78M |
|
$2.23M |
|
$1.53M |
|
$4.41M |
|
$-0.66M |
|
$0.13M |
|
$-0.53M |
|
$-0.53M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.66M |
|
$-0.62M |
|
1.24M |
|
1.24M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$12.65M |
|
$0.23M |
|
$1.04M |
|
$13.69M |
|
$4.10M |
|
-- |
|
$5.19M |
|
$9.28M |
|
$4.41M |
|
$4.41M |
|
$4.41M |
|
1.63M |
|
| Cash Flow Statement Financials | |
$-0.09M |
|
$-0.08M |
|
$3.03M |
|
$3.13M |
|
$5.37M |
|
$2.25M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.09 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
40.70% |
|
-17.47% |
|
-17.47% |
|
-- |
|
-14.06% |
|
-20.67% |
|
$-0.17M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.76 |
|
1.68 |
|
53.51 |
|
-17.59% |
|
-17.59% |
|
-5.67% |
|
|
Return on Investments |
-17.59% |
$2.70 |
|
$-0.14 |
|
$-0.07 |
|